國際乙肝會議； 2022年9月18-22日； 法國巴黎
Kosh Agarwal,1 Man-Fung Yuen,2 Heiner Wedemeyer,3 Daniel Cloutier,4 Ling Shen,4 Andre Arizpe,4 Sneha V. Gupta,4 Marie Fanget,4 Lillian Seu,4 Andrea L. Cathcart,4 Audrey H. Lau ,4 凱莉黃,4 愛德華 Gane5
1 英國倫敦國王學院醫院肝臟研究所； 2香港大學瑪麗醫院，中國香港； 3德國漢諾威醫學院胃腸病學、肝病學和內分泌學系； 4Vir Biotechnology, Inc.，舊金山，加利福尼亞州，美國；
5奧克蘭大學醫學院，奧克蘭，新西蘭
Dose-Dependent Durability of Hepatitis B Surface Antigen Reductions Following Administration of a Single Dose of VIR-3434, an Investigational, Neutralizing Vaccinal Monoclonal Antibody
International HBV Meeting; September 18-22, 2022; Paris, France
Kosh Agarwal,1 Man-Fung Yuen,2 Heiner Wedemeyer,3 Daniel Cloutier,4 Ling Shen,4 Andre Arizpe,4 Sneha V. Gupta,4 Marie Fanget,4 Lillian Seu,4 Andrea L. Cathcart,4 Audrey H. Lau,4 Carey Hwang,4 Edward Gane5
1Institute of Liver Studies, King’s College Hospital, London, United Kingdom; 2Queen Mary Hospital, The University of Hong Kong, Hong Kong, China; 3Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; 4Vir Biotechnology, Inc., San Francisco, CA, USA;
5Faculty of Medicine, University of Auckland, Auckland, New Zealand